Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2012

Open Access 01-12-2012 | Research article

Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study

Authors: Clare Liddy, Jatinderpreet Singh, William Hogg, Simone Dahrouge, Catherine Deri-Armstrong, Grant Russell, Monica Taljaard, Ayub Akbari, George Wells

Published in: BMC Cardiovascular Disorders | Issue 1/2012

Login to get access

Abstract

Background

Primary care plays a key role in the prevention and management of cardiovascular disease (CVD). We examined primary care practice adherence to recommended care guidelines associated with the prevention and management of CVD for high risk patients.

Methods

We conducted a secondary analysis of cross-sectional baseline data collected from 84 primary care practices participating in a large quality improvement initiative in Eastern Ontario from 2008 to 2010. We collected medical chart data from 4,931 patients who either had, or were at high risk of developing CVD to study adherence rates to recommended guidelines for CVD care and to examine the proportion of patients at target for clinical markers such as blood pressure, lipid levels and hemoglobin A1c.

Results

Adherence to preventive care recommendations was poor. Less than 10% of high risk patients received a waistline measurement, half of the smokers received cessation advice, and 7.7% were referred to a smoking cessation program. Gaps in care exist for diabetes and kidney disease as 54.9% of patients with diabetes received recommended hemoglobin-A1c screenings, and only 55.8% received an albumin excretion test. Adherence rates to recommended guidelines for coronary artery disease, hypertension, and dyslipidemia were high (>75%); however <50% of patients were at target for blood pressure or LDL-cholesterol levels (37.1% and 49.7% respectively), and only 59.3% of patients with diabetes were at target for hemoglobin-A1c.

Conclusions

There remain significant opportunities for primary care providers to engage high risk patients in prevention activities such as weight management and smoking cessation. Despite high adherence rates for hypertension, dyslipidemia, and coronary artery disease, a significant proportion of patients failed to meet treatment targets, highlighting the complexity of caring for people with multiple chronic conditions.

Trial Registration

NCT00574808
Literature
1.
go back to reference Campbell NR, Onysko J, Johansen H, Gao RN: Changes in cardiovascular deaths and hospitalization in Canada. Can J Cardiol. 2006, 22: 425-427. 10.1016/S0828-282X(06)70929-1.CrossRefPubMedPubMedCentral Campbell NR, Onysko J, Johansen H, Gao RN: Changes in cardiovascular deaths and hospitalization in Canada. Can J Cardiol. 2006, 22: 425-427. 10.1016/S0828-282X(06)70929-1.CrossRefPubMedPubMedCentral
2.
go back to reference Johansen H, Thillaiampalam S, Nguyen D, Sambell C: Diseases of the circulatory system–hospitalization and mortality. Health Rep. 2005, 17: 49-53.PubMed Johansen H, Thillaiampalam S, Nguyen D, Sambell C: Diseases of the circulatory system–hospitalization and mortality. Health Rep. 2005, 17: 49-53.PubMed
3.
go back to reference Blackadar R, Houle M: The Alberta Cardiac Access Collaborative: improving the cardiac patient journey. Healthc Q. 2009, 13: Spec No:85-Spec No:90.CrossRefPubMed Blackadar R, Houle M: The Alberta Cardiac Access Collaborative: improving the cardiac patient journey. Healthc Q. 2009, 13: Spec No:85-Spec No:90.CrossRefPubMed
4.
go back to reference Boyd DR, Genuis SJ: The environmental burden of disease in Canada: respiratory disease, cardiovascular disease, cancer, and congenital affliction. Environ Res. 2008, 106: 240-249. 10.1016/j.envres.2007.08.009.CrossRefPubMed Boyd DR, Genuis SJ: The environmental burden of disease in Canada: respiratory disease, cardiovascular disease, cancer, and congenital affliction. Environ Res. 2008, 106: 240-249. 10.1016/j.envres.2007.08.009.CrossRefPubMed
5.
go back to reference Manuel DG, Leung M, Nguyen K, Tanuseputro P, Johansen H: Burden of cardiovascular disease in Canada. Can J Cardiol. 2003, 19: 997-1004.PubMed Manuel DG, Leung M, Nguyen K, Tanuseputro P, Johansen H: Burden of cardiovascular disease in Canada. Can J Cardiol. 2003, 19: 997-1004.PubMed
6.
go back to reference Heart and Stroke Foundation of Canada: The Growing Burden of Heart Disease and Stroke in Canada. 2003, Heart and Stroke Foundation, Canada Heart and Stroke Foundation of Canada: The Growing Burden of Heart Disease and Stroke in Canada. 2003, Heart and Stroke Foundation, Canada
7.
go back to reference Glazier RH, Moineddin R, Agha MM: The Impact of not having a primary care physician among people with chronic conditions. ICES Investigative Report. 2008, Institute for Clinical Evaluative Sciences, Toronto Glazier RH, Moineddin R, Agha MM: The Impact of not having a primary care physician among people with chronic conditions. ICES Investigative Report. 2008, Institute for Clinical Evaluative Sciences, Toronto
9.
go back to reference Cifuentes M, Fernald DH, Green LA, Niebauer LJ, Crabtree BF, Stange KC, Hassmiller SB: Prescription for health: changing primary care practice to foster healthy behaviors. Ann Fam Med. 2005, 3 (Suppl 2): S4-S11.CrossRefPubMedPubMedCentral Cifuentes M, Fernald DH, Green LA, Niebauer LJ, Crabtree BF, Stange KC, Hassmiller SB: Prescription for health: changing primary care practice to foster healthy behaviors. Ann Fam Med. 2005, 3 (Suppl 2): S4-S11.CrossRefPubMedPubMedCentral
10.
go back to reference Liddy C, Hogg W, Russell G, Wells G, Armstrong CD, Akbari A, Dahrouge S, Taljaard M, Mayo-Bruinsma L, Singh J, et al: Improved delivery of cardiovascular care (IDOCC) through outreach facilitation: study protocol and implementation details of a cluster randomized controlled trial in primary care. Implement Sci. 2011, 6: 110-10.1186/1748-5908-6-110.CrossRefPubMedPubMedCentral Liddy C, Hogg W, Russell G, Wells G, Armstrong CD, Akbari A, Dahrouge S, Taljaard M, Mayo-Bruinsma L, Singh J, et al: Improved delivery of cardiovascular care (IDOCC) through outreach facilitation: study protocol and implementation details of a cluster randomized controlled trial in primary care. Implement Sci. 2011, 6: 110-10.1186/1748-5908-6-110.CrossRefPubMedPubMedCentral
11.
go back to reference Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A: Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001, 20: 64-78. 10.1377/hlthaff.20.6.64.CrossRef Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A: Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001, 20: 64-78. 10.1377/hlthaff.20.6.64.CrossRef
12.
go back to reference Bains N: Population Health Profile: Champlain LHIN. Champlain LHIN. 2008, 1-4. Bains N: Population Health Profile: Champlain LHIN. Champlain LHIN. 2008, 1-4.
13.
go back to reference Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847. 10.1161/01.CIR.97.18.1837.CrossRefPubMed Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847. 10.1161/01.CIR.97.18.1837.CrossRefPubMed
14.
go back to reference Hogg W, Gyorfi-Dyke E, Johnston S, Dahrouge S, Liddy C, Russell G, Kristjansson E: Conducting chart audits in practice-based primary care research: a user's guide. Can Fam Physician. 2010, 56: 495-496.PubMedPubMedCentral Hogg W, Gyorfi-Dyke E, Johnston S, Dahrouge S, Liddy C, Russell G, Kristjansson E: Conducting chart audits in practice-based primary care research: a user's guide. Can Fam Physician. 2010, 56: 495-496.PubMedPubMedCentral
15.
go back to reference Liddy C, Wiens M, Hogg W: Methods to achieve high interrater reliability in data collection from primary care medical records. Ann Fam Med. 2011, 9: 57-62. 10.1370/afm.1195.CrossRefPubMedPubMedCentral Liddy C, Wiens M, Hogg W: Methods to achieve high interrater reliability in data collection from primary care medical records. Ann Fam Med. 2011, 9: 57-62. 10.1370/afm.1195.CrossRefPubMedPubMedCentral
16.
go back to reference Montoya L, Liddy C, Hogg W, Papadakis S, Dojeiji L, Russell G, Akbari A, Pipe A, Higginson L: Development of the Champlain primary care cardiovascular disease prevention and management guideline: tailoring evidence to community practice. Can Fam Physician. 2011, 57: e202-e207.PubMedPubMedCentral Montoya L, Liddy C, Hogg W, Papadakis S, Dojeiji L, Russell G, Akbari A, Pipe A, Higginson L: Development of the Champlain primary care cardiovascular disease prevention and management guideline: tailoring evidence to community practice. Can Fam Physician. 2011, 57: e202-e207.PubMedPubMedCentral
17.
go back to reference AGREE Collaboration: Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE Project. Qual Saf Health Care. 2003, 12: 18-23.CrossRef AGREE Collaboration: Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE Project. Qual Saf Health Care. 2003, 12: 18-23.CrossRef
18.
go back to reference Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in Health Research. 2000, Wiley, New York Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in Health Research. 2000, Wiley, New York
19.
go back to reference SAS Institute Inc: SAS 9.2. 2008, Cary, NC, USA SAS Institute Inc: SAS 9.2. 2008, Cary, NC, USA
20.
go back to reference Bullen C: Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther. 2008, 6: 883-895. 10.1586/14779072.6.6.883.CrossRefPubMed Bullen C: Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther. 2008, 6: 883-895. 10.1586/14779072.6.6.883.CrossRefPubMed
21.
go back to reference Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003, 290 (1): 86-97. 10.1001/jama.290.1.86.CrossRefPubMed Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003, 290 (1): 86-97. 10.1001/jama.290.1.86.CrossRefPubMed
22.
go back to reference Ford ES, Bergmann MM, Kroger J, Schienkiewitz A, Weikert C, Boeing H: Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch Intern Med. 2009, 169: 1355-1362.CrossRefPubMed Ford ES, Bergmann MM, Kroger J, Schienkiewitz A, Weikert C, Boeing H: Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study. Arch Intern Med. 2009, 169: 1355-1362.CrossRefPubMed
23.
go back to reference Center for Disease Control and Prevention: Smoking-cessation advice from health-care providers- Canada 2005. MMWR Morb Mortal Wkly Rep. 2007, 56: 1145-1154. Center for Disease Control and Prevention: Smoking-cessation advice from health-care providers- Canada 2005. MMWR Morb Mortal Wkly Rep. 2007, 56: 1145-1154.
24.
go back to reference Holtrop JS, Malouin R, Weismantel D, Wadland WC: Clinician perceptions of factors influencing referrals to a smoking cessation program. BMC Fam Pract. 2008, 9: 18-10.1186/1471-2296-9-18.CrossRefPubMedPubMedCentral Holtrop JS, Malouin R, Weismantel D, Wadland WC: Clinician perceptions of factors influencing referrals to a smoking cessation program. BMC Fam Pract. 2008, 9: 18-10.1186/1471-2296-9-18.CrossRefPubMedPubMedCentral
25.
go back to reference Schnoll RA, Rukstalis M, Wileyto EP, Shields AE: Smoking cessation treatment by primary care physicians: An update and call for training. Am J Prev Med. 2006, 31: 233-239. 10.1016/j.amepre.2006.05.001.CrossRefPubMed Schnoll RA, Rukstalis M, Wileyto EP, Shields AE: Smoking cessation treatment by primary care physicians: An update and call for training. Am J Prev Med. 2006, 31: 233-239. 10.1016/j.amepre.2006.05.001.CrossRefPubMed
26.
go back to reference Puska PM, Barrueco M, Roussos C, Hider A, Hogue S: The participation of health professionals in a smoking-cessation programme positively influences the smoking cessation advice given to patients. Int J Clin Pract. 2005, 59: 447-452. 10.1111/j.1368-5031.2005.00492.x.CrossRefPubMed Puska PM, Barrueco M, Roussos C, Hider A, Hogue S: The participation of health professionals in a smoking-cessation programme positively influences the smoking cessation advice given to patients. Int J Clin Pract. 2005, 59: 447-452. 10.1111/j.1368-5031.2005.00492.x.CrossRefPubMed
27.
go back to reference Stead M, Angus K, Holme I, Cohen D, Tait G: Factors influencing European GPs' engagement in smoking cessation: a multi-country literature review. Br J Gen Pract. 2009, 59: 682-690. 10.3399/bjgp09X454007.CrossRefPubMedPubMedCentral Stead M, Angus K, Holme I, Cohen D, Tait G: Factors influencing European GPs' engagement in smoking cessation: a multi-country literature review. Br J Gen Pract. 2009, 59: 682-690. 10.3399/bjgp09X454007.CrossRefPubMedPubMedCentral
28.
go back to reference Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K: The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control. 2007, 16 (Suppl 1): i53-i59.CrossRefPubMedPubMedCentral Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K: The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control. 2007, 16 (Suppl 1): i53-i59.CrossRefPubMedPubMedCentral
29.
go back to reference Lai DT, Cahill K, Qin Y, Tang JL: Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2010, CD006936: 1-37. Lai DT, Cahill K, Qin Y, Tang JL: Motivational interviewing for smoking cessation. Cochrane Database Syst Rev. 2010, CD006936: 1-37.
30.
go back to reference Almdal T, Scharling H, Jensen JS, Vestergaard H: The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004, 164: 1422-1426. 10.1001/archinte.164.13.1422.CrossRefPubMed Almdal T, Scharling H, Jensen JS, Vestergaard H: The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004, 164: 1422-1426. 10.1001/archinte.164.13.1422.CrossRefPubMed
31.
go back to reference Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, Altafullah I, Ledbetter LY, MacLeod MJ, Scott R, et al: Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol. 2011, 68: 1245-1251. 10.1001/archneurol.2011.146.CrossRefPubMed Callahan A, Amarenco P, Goldstein LB, Sillesen H, Messig M, Samsa GP, Altafullah I, Ledbetter LY, MacLeod MJ, Scott R, et al: Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Arch Neurol. 2011, 68: 1245-1251. 10.1001/archneurol.2011.146.CrossRefPubMed
32.
go back to reference Haffner SM: Coronary heart disease in patients with diabetes. N Engl J Med. 2000, 342: 1040-1042. 10.1056/NEJM200004063421408.CrossRefPubMed Haffner SM: Coronary heart disease in patients with diabetes. N Engl J Med. 2000, 342: 1040-1042. 10.1056/NEJM200004063421408.CrossRefPubMed
33.
go back to reference Saydah SH, Eberhardt MS, Loria CM, Brancati FL: Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002, 156: 714-719. 10.1093/aje/kwf111.CrossRefPubMed Saydah SH, Eberhardt MS, Loria CM, Brancati FL: Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002, 156: 714-719. 10.1093/aje/kwf111.CrossRefPubMed
34.
go back to reference Agha A, Dillon D, Corbett M, Sreenan S: Target blood pressure for patients with type 2 diabetes is difficult to achieve in the setting of a busy diabetes clinic. Ir J Med Sci. 2003, 172: 168-170. 10.1007/BF02915282.CrossRefPubMed Agha A, Dillon D, Corbett M, Sreenan S: Target blood pressure for patients with type 2 diabetes is difficult to achieve in the setting of a busy diabetes clinic. Ir J Med Sci. 2003, 172: 168-170. 10.1007/BF02915282.CrossRefPubMed
35.
go back to reference Kennedy AG, MacLean CD, Littenberg B, Ades PA, Pinckney RG: The challenge of achieving national cholesterol goals in patients with diabetes. Diabetes Care. 2005, 28: 1029-1034. 10.2337/diacare.28.5.1029.CrossRefPubMed Kennedy AG, MacLean CD, Littenberg B, Ades PA, Pinckney RG: The challenge of achieving national cholesterol goals in patients with diabetes. Diabetes Care. 2005, 28: 1029-1034. 10.2337/diacare.28.5.1029.CrossRefPubMed
36.
go back to reference Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004, 291: 335-342. 10.1001/jama.291.3.335.CrossRefPubMed Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004, 291: 335-342. 10.1001/jama.291.3.335.CrossRefPubMed
37.
go back to reference Program CHE: 2011 Canadian Hypertension Education Program recommendations: An annual update. Can Fam Physician. 2011, 57: 1393-1397. Program CHE: 2011 Canadian Hypertension Education Program recommendations: An annual update. Can Fam Physician. 2011, 57: 1393-1397.
38.
go back to reference Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Lum-Kwong MM, Fodor G: Results of the Ontario survey on the prevalence and control of hypertension. CMAJ. 2008, 178: 1441-1449. 10.1503/cmaj.071340.CrossRefPubMedPubMedCentral Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Lum-Kwong MM, Fodor G: Results of the Ontario survey on the prevalence and control of hypertension. CMAJ. 2008, 178: 1441-1449. 10.1503/cmaj.071340.CrossRefPubMedPubMedCentral
39.
go back to reference McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, Tremblay MS, Walker R, Johansen H, Campbell N: Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011, 183: 1007-1013. 10.1503/cmaj.101767.CrossRefPubMedPubMedCentral McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, Tremblay MS, Walker R, Johansen H, Campbell N: Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ. 2011, 183: 1007-1013. 10.1503/cmaj.101767.CrossRefPubMedPubMedCentral
40.
go back to reference Egan BM, Zhao Y, Axon RN: US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010, 303: 2043-2050. 10.1001/jama.2010.650.CrossRefPubMed Egan BM, Zhao Y, Axon RN: US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010, 303: 2043-2050. 10.1001/jama.2010.650.CrossRefPubMed
41.
go back to reference Pereira M, Lunet N, Azevedo A, Barros H: Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009, 27: 963-975. 10.1097/HJH.0b013e3283282f65.CrossRefPubMed Pereira M, Lunet N, Azevedo A, Barros H: Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009, 27: 963-975. 10.1097/HJH.0b013e3283282f65.CrossRefPubMed
42.
go back to reference Bolli P, Campbell NR: Do recommendations for the management of hypertension improve cardiovascular outcome?. The canadian experience. Int J Hypertens. 2011, 2011: 410754-PubMed Bolli P, Campbell NR: Do recommendations for the management of hypertension improve cardiovascular outcome?. The canadian experience. Int J Hypertens. 2011, 2011: 410754-PubMed
43.
go back to reference Akbari A, Swedko PJ, Clark HD, Hogg W, Lemelin J, Magner P, Moore L, Ooi D: Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med. 2004, 164: 1788-1792. 10.1001/archinte.164.16.1788.CrossRefPubMed Akbari A, Swedko PJ, Clark HD, Hogg W, Lemelin J, Magner P, Moore L, Ooi D: Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med. 2004, 164: 1788-1792. 10.1001/archinte.164.16.1788.CrossRefPubMed
44.
go back to reference Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD: Primary care management of chronic kidney disease. J Gen Intern Med. 2011, 26: 386-392. 10.1007/s11606-010-1523-6.CrossRefPubMed Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD: Primary care management of chronic kidney disease. J Gen Intern Med. 2011, 26: 386-392. 10.1007/s11606-010-1523-6.CrossRefPubMed
45.
go back to reference Jain A, Hemmelgarn BR: Impact of estimated glomerular filtration rate reporting on nephrology referrals: a review of the literature. Curr Opin Nephrol Hypertens. 2011, 20: 218-223. 10.1097/MNH.0b013e3283446193.CrossRefPubMed Jain A, Hemmelgarn BR: Impact of estimated glomerular filtration rate reporting on nephrology referrals: a review of the literature. Curr Opin Nephrol Hypertens. 2011, 20: 218-223. 10.1097/MNH.0b013e3283446193.CrossRefPubMed
46.
go back to reference National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. 1998, NIH Publications, Bethesda National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. 1998, NIH Publications, Bethesda
47.
go back to reference Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB: Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008, 117: 1658-1667. 10.1161/CIRCULATIONAHA.107.739714.CrossRefPubMed Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB: Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008, 117: 1658-1667. 10.1161/CIRCULATIONAHA.107.739714.CrossRefPubMed
48.
go back to reference Douketis JD, Paradis G, Keller H, Martineau C: Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CMAJ. 2005, 172: 995-998. 10.1503/cmaj.045170.CrossRefPubMedPubMedCentral Douketis JD, Paradis G, Keller H, Martineau C: Canadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease risk. CMAJ. 2005, 172: 995-998. 10.1503/cmaj.045170.CrossRefPubMedPubMedCentral
49.
go back to reference Brown P: Waist circumference in primary care. Prim Care Diabetes. 2009, 3: 259-261. 10.1016/j.pcd.2009.09.006.CrossRefPubMed Brown P: Waist circumference in primary care. Prim Care Diabetes. 2009, 3: 259-261. 10.1016/j.pcd.2009.09.006.CrossRefPubMed
50.
go back to reference Dunkley AJ, Stone MA, Patel N, Davies MJ, Khunti K: Waist circumference measurement: knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population. Fam Pract. 2009, 26: 365-371. 10.1093/fampra/cmp048.CrossRefPubMed Dunkley AJ, Stone MA, Patel N, Davies MJ, Khunti K: Waist circumference measurement: knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population. Fam Pract. 2009, 26: 365-371. 10.1093/fampra/cmp048.CrossRefPubMed
51.
go back to reference McPherson R, Frohlich J, Fodor G, Genest J: Canadian Cardiovascular Society: Canadian Cardiovascular Society position statement–recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol. 2006, 22: 913-927. 10.1016/S0828-282X(06)70310-5.CrossRefPubMedPubMedCentral McPherson R, Frohlich J, Fodor G, Genest J: Canadian Cardiovascular Society: Canadian Cardiovascular Society position statement–recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol. 2006, 22: 913-927. 10.1016/S0828-282X(06)70310-5.CrossRefPubMedPubMedCentral
52.
go back to reference McKenney JM: Optimizing LDL-C lowering with statins. Am J Ther. 2004, 11: 54-59. 10.1097/00045391-200401000-00011.CrossRefPubMed McKenney JM: Optimizing LDL-C lowering with statins. Am J Ther. 2004, 11: 54-59. 10.1097/00045391-200401000-00011.CrossRefPubMed
53.
go back to reference Senecal M, Fodor G, Gagne C, Genest J, Lavoie MA, McPherson R, Marentette M, Sebaldt RJ: Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study–observational. Curr Med Res Opin. 2009, 25: 47-55. 10.1185/03007990802575734.CrossRefPubMed Senecal M, Fodor G, Gagne C, Genest J, Lavoie MA, McPherson R, Marentette M, Sebaldt RJ: Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study–observational. Curr Med Res Opin. 2009, 25: 47-55. 10.1185/03007990802575734.CrossRefPubMed
54.
go back to reference Fortin M, Contant E, Savard C, Hudon C, Poitras ME, Almirall J: Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity. BMC Fam Pract. 2011, 12: 74-10.1186/1471-2296-12-74.CrossRefPubMedPubMedCentral Fortin M, Contant E, Savard C, Hudon C, Poitras ME, Almirall J: Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity. BMC Fam Pract. 2011, 12: 74-10.1186/1471-2296-12-74.CrossRefPubMedPubMedCentral
56.
go back to reference Van WC, Schellevis FG: Comorbidity and guidelines: conflicting interests. Lancet. 2006, 367: 550-551. 10.1016/S0140-6736(06)68198-1.CrossRef Van WC, Schellevis FG: Comorbidity and guidelines: conflicting interests. Lancet. 2006, 367: 550-551. 10.1016/S0140-6736(06)68198-1.CrossRef
57.
go back to reference Liddy C, Singh J, Hogg W, Dahrouge S, Taljaard M: Comparison of primary care models in the prevention of cardiovascular disease - a cross sectional study. BMC Fam Pract. 2011, 12: 114-10.1186/1471-2296-12-114.CrossRefPubMedPubMedCentral Liddy C, Singh J, Hogg W, Dahrouge S, Taljaard M: Comparison of primary care models in the prevention of cardiovascular disease - a cross sectional study. BMC Fam Pract. 2011, 12: 114-10.1186/1471-2296-12-114.CrossRefPubMedPubMedCentral
Metadata
Title
Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study
Authors
Clare Liddy
Jatinderpreet Singh
William Hogg
Simone Dahrouge
Catherine Deri-Armstrong
Grant Russell
Monica Taljaard
Ayub Akbari
George Wells
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2012
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-12-74

Other articles of this Issue 1/2012

BMC Cardiovascular Disorders 1/2012 Go to the issue